You appear to be offline. Some data may be unavailable until your connection is restored.

AMGN

Stock

Amgen Inc.

Create price alert

Description

Amgen Inc. is a global biotechnology company that discovers, develops, manufactures and markets biologic medicines for serious illnesses such as cancer, cardiovascular disease, bone loss, inflammatory conditions and rare diseases. Its business model relies on extensive research‑and‑development investment, a portfolio of approved biologic therapies and a pipeline of candidates across all stages of clinical testing, with products sold worldwide through wholesale distributors and direct relationships with health‑care providers. Operating in the biotechnology and pharmaceutical sector, Amgen is one of the largest independent biotech firms, a component of the Dow Jones Industrial Average and recognized for flagship biologics like Enbrel, Neulasta, Prolia and Xgeva, as well as the recent addition of Horizon Therapeutics’ rare‑disease drugs.

Dividend

2.30%annual yield
quarterly payout
Ex-Dividend: Nov 20, 2026 (est.)
Payment: Dec 11, 2026 (est.)
Dividend history
AmountEx-DatePayment Date
$2.52Aug 21, 2026Sep 11, 2026
$2.52May 15, 2026Jun 5, 2026
$2.52Feb 13, 2026Mar 6, 2026

Track every AMGN dividend

Get reminders ahead of AMGN's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.